ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 168 filers reported holding ACCELERON PHARMA INC in Q2 2019. The put-call ratio across all filers is 1.56 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $35,313,000 | +4.1% | 205,187 | -24.1% | 0.01% | +10.0% |
| Q2 2021 | $33,931,000 | -8.1% | 270,386 | -0.7% | 0.01% | -16.7% |
| Q1 2021 | $36,910,000 | +2.9% | 272,181 | -2.9% | 0.01% | 0.0% |
| Q4 2020 | $35,868,000 | +56.6% | 280,343 | +37.7% | 0.01% | +33.3% |
| Q3 2020 | $22,908,000 | +61.3% | 203,577 | +36.6% | 0.01% | +50.0% |
| Q2 2020 | $14,201,000 | -58.3% | 149,059 | -60.7% | 0.01% | -64.7% |
| Q1 2020 | $34,070,000 | +234.1% | 379,099 | +97.1% | 0.02% | +325.0% |
| Q4 2019 | $10,199,000 | +33.8% | 192,363 | -0.3% | 0.00% | +33.3% |
| Q3 2019 | $7,622,000 | -4.5% | 192,909 | -0.7% | 0.00% | 0.0% |
| Q2 2019 | $7,983,000 | – | 194,332 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 1,400,000 | $133,378,000 | 3.73% |
| Foresite Capital Management III, LLC | 42,030 | $4,004,000 | 3.56% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 257,249 | $24,508,000 | 2.23% |
| Cormorant Asset Management, LP | 600,000 | $57,162,000 | 2.18% |
| Avoro Capital Advisors LLC | 1,040,000 | $99,081,000 | 1.96% |
| QVT Financial LP | 101,396 | $9,660,000 | 1.64% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,100,000 | $200,067,000 | 1.60% |
| Rhenman & Partners Asset Management AB | 155,000 | $14,767,000 | 1.60% |
| Parkman Healthcare Partners LLC | 57,500 | $5,478,000 | 1.54% |
| Ikarian Capital, LLC | 187,700 | $17,882,000 | 1.42% |